pSivida Corp Reports ILUVIEN® To Be Funded By UK??'s National...
NICE requires clinical commissioning groups, the National Health Service England and local public health authorities to comply with the recommendation in the final guidance within three months of its date of publication.
Intraday Movers - Penn Virginia Corporation (NYSE:PVA), Zogenix, Inc. ...
PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits - even in bear markets.
Canaccord Genuity Reiterates Buy Rating for Penn Virginia Corp.
's stock had its "buy" rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Friday, Analyst Ratings News reports.
Penn Virginia Corp. Stock Rating Reaffirmed by Jefferies Group
's stock had its "buy" rating reiterated by Jefferies Group in a research note issued on Friday, AnalystRatings.Net reports.
Research Alert-Penn Virginia: Howard Weil raises price target
Penn Virginia Corp : * Howard Weil raises price target to $14 from $12; rating sector outperform For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters ... (more)
pSivida Corp Reports First Quarter 2014 Results
"We made excellent progress this quarter in advancing our own pipeline of products, including our lead development product, Medidura for posterior uveitis, now in a Phase III trial, and in enhancing our capital with a $10.8 million public offering of our common stock," said Dr. Paul Ashton, President and CEO of pSivida.
Wednesday's ETF Movers: FCG, GXC
In trading on Wednesday, the First Trust ISE-Revere Natural Gas Index Fund is outperforming other ETFs, up about 1.3% on the day.
Watch List: Boston Scientific Corporation (NYSE:BSX), Penn Virginia...
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis.
The Motley Fool
Attention Bargain Hunters: Magnum Hunter Has Run Its Course
What is the secret behind Magnum's success? What has pushed Magnum to new highs for 2013? Does this rally have legs? To find the answers, let's dig deeper into this company.